Research Projects & Grants

For Profit Organization

  • Safety and Therapeutic Measures of Transcranial Cathodal Direct Current Stimulation (TDCS) in Patients with Refractory Focal Epilepsy. Protocol #: NE001, Role: PI, Neuroelectrics Corporation, (08/2025 - 08/2026) Status: Approved
  • A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi center Trial of CVL-865 as Adjunctive Therapy in Adults with Drug-Resistant Focal Onset Seizures (REALIZE TRIAL). Protocol Number: CVL-865-SZ-001, Role: Investigator, Cerevel Therapeutics, LLC, (06/2023 - 06/2024) Status: Completed
  • ASCEND: Vagus nerve stimulation titration protocol to improve tolerance and accelerate adaptation, Role: Investigator, Cyberonics, Inc., (03/2016 - 03/2017) Status: Completed
  • Long-term eslicarbazepine acetate extension study. Protocol # 093-050, version 3.0, dated 24 Jul 2009. Informed consent form version dated 03Aug09. Investigator's brochure version 1.0, dated 26 Jan 2009, Role: Investigator, Sepracor, (09/2015 - 09/2016) Status: Completed
  • A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1). Protocol: PRAX-628-321, Role: PI, Praxis Precision Medicines, Inc., (06/2025 - 06/2026) Status: Approved

Internal

  • The incidence of seizures on electroencephalography (EEG) in non-neurologic intensive care unit (ICU) settings, Role: Investigator, LLU Dept. of Neurology, (12/2023) Status: Approved
  • Tracking Quality of Life and Seizure Burden in Epilepsy Surgical Candidates in Inland Southern California, Role: Investigator, LLU Dept. of Neurology, (03/2022) Status: Approved
  • Early detection of Dementia using Loma Linda Learning and Memory Assessment (LLAMA), Role: Investigator, LLU Dept. of Neurology, (04/2026) Status: Approved